Decoy Therapeutics Stock (NASDAQ:DCOY)

Financials Chart

Previous Close

$5.84

52W Range

$5.40 - $415.80

50D Avg

$7.74

200D Avg

$43.24

Market Cap

$3.23M

Avg Vol (3M)

$30.45K

Beta

0.36

Div Yield

-

DCOY Company Profile

Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company is headquartered in Cambridge, MA.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Jan 29, 2015

Website

DCOY Performance

DCOY Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	-	-	-
Operating Income	$-12.61M	$-5.73M	$-12.89M
Net Income	$-12.52M	$-5.58M	$-12.54M
EBITDA	$-12.61M	$-5.73M	$-12.88M
Basic EPS	$-129.10	$-86.85	$-0.06
Diluted EPS	$-129.10	$-86.85	$-0.06

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q2 22Aug 08, 22 | 11:00 AM

Q1 22May 12, 22 | 5:00 PM

Q4 21Mar 10, 22 | 5:00 PM

Peer Comparison

Ticker	Company
PBM	Psyence Biomedical Ltd.
SPRC	SciSparc Ltd.
GTBP	GT Biopharma, Inc.
REVB	Revelation Biosciences, Inc.
SLXN	Silexion Therapeutics Ltd.
INDP	Indaptus Therapeutics, Inc.
ENVB	Enveric Biosciences, Inc.